{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "QUV",
      "openfda": {
        "k_number": [
          "DEN220017"
        ],
        "registration_number": [
          "1932738",
          "9614559"
        ],
        "fei_number": [
          "3002806942",
          "1000143606"
        ]
      },
      "review_panel": "RA",
      "medical_specialty": "RA",
      "device_name": "Phase-Changing Fiducial Marker For Radiation Therapy",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Radiology",
      "device_class": "2",
      "definition": "A phase-changing fiducial marker for radiation therapy is a single-use, sterile liquid material that changes phase in situ when injected in tissue for the purposes of aiding radiation therapy treatment.  The device is intended to be visualized using one or more radiologic imaging modalities.",
      "regulation_number": "892.5727",
      "implant_flag": "Y",
      "submission_type_id": "1"
    }
  ]
}